SCHEMBL4811316

SCHEMBL4811316

CC(c1ccccc1)N1CCCC(CN2CCN(c3ccc4cccnc4n3)CC2)C1.Cc1nc2ccccc2nc1N1CCN(CC2CCCN(C(C)c3ccccc3)C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORD Q00796 1/20 0.41
PIM1 P11309 1/20 0.39
PDE10A Q9Y233 4/20 0.38
CYP1A2 P05177 1/20 0.36
TSHR P16473 1/20 0.36
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CXCR4 P61073 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
HTR3A P46098 1/20 0.33
PDE2A O00408 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778491 0.91 PIM1 (0.41) PIM1PDE10AHTR1AHTR7KDM4E
SCHEMBL1777611 0.88 CYP1A2 (0.46) SORDPIM1CYP1A2TSHRHRH4
SCHEMBL1778333 0.82 KDM4E (0.51) SORDPDE10ACYP1A2HTR1AHRH4
SCHEMBL1779775 0.78 HTR1A (0.39) TSHRHTR1AKDM4EALDH1A1LMNA
SCHEMBL1777057 0.78 NPC1 (0.49) SORDPIM1PDE10AHRH4KDM4E
SCHEMBL1779944 0.75 KCNH2 (0.40) PIM1PDE10AKDM4EALDH1A1LMNA
SCHEMBL4811312 0.75 SORD (0.41) SORDPDE10ACYP1A2TSHRHRH4
SCHEMBL1778794 0.75 HTR1A (0.44) PIM1HTR1AKDM4EALDH1A1LMNA
SCHEMBL1778487 0.72 CCR2 (0.45) PIM1PDE10AKDM4E
SCHEMBL1777607 0.69 HRH4 (0.48) CYP1A2TSHRHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966187-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071952-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2007-06-28 WO disclosed